Municipal Wastewater in Ottawa, Canada contains a reservoir of bacteriophages with clinically relevant Escherichia coli and Klebsiella pneumoniae hosts
Preprint
Abstract
2. The recent rise of antimicrobial resistant bacteria in health care and environmental settings has been detrimental to the feasibility of antibiotic treatments for patients and agricultural applications. Along with this escalating issue, a resurgence of bacteriophage research has occurred, and phage therapy is proving to be a powerful case-specific alternative. However, a centralized source of phages that are accessible, abundant, and characterized as candidates for potential use in therapeutic applications remains to be fully established. This study aims to identify the range of bacteriophages available in municipal wastewater from Ottawa, Ontario that can infect and lyse Escherichia coli O1:K1:H7 and Klebsiella pneumoniae K3 hosts. Building-level sewer shed, influent, and primary sludge samples were screened for the presence of these phages which were then isolated through several rounds of plaque purification, sequenced by Nanopore technology, and annotated. Ten phages belonging to the genus Kayfunavirus, Vectrevirus, Kuravirus , or Sugarlandvirus were identified and bio-banked from different types of wastewater at several time points. These phages are 96-99% identical to phages isolated in Germany, Switzerland, and Spain, but contain divergent structural and metabolic genes. This work contributes to the ever-growing database of sequenced phages, provided with a physical archive of the organisms, and helps uncover the extent of phage biodiversity at different levels of wastewater treatment facilities that are readily available for screening in phage therapy applications.Keywords
Funding Information
- CHEO Foundation, Research Growth Award
This publication has 76 references indexed in Scilit:
- Unveiling Novel Lytic Bacteriophages as Natural Biocontrol Agents Against Multidrug-Resistant Escherichia coli: Isolation, Characterization, and In vitro ApplicationFood and Environmental Virology, 2026
- PSK1, a bacteriophage with antibacterial activity against extended-spectrum-beta-lactamase-producing Escherichia coli sequence type 131 with serotype O25:H4Archives of Virology, 2025
- Phage Therapy for Urinary Tract Infections: Progress and Challenges AheadInternational Urogynecology Journal, 2025
- Genome sequencing of Escherichia coli phage UFJF_EcSW4 reveals a novel lytic Kayfunavirus species3 Biotech, 2024
- Isolation and characterization of a relatively broad-spectrum phage against Escherichia coliArchives of Microbiology, 2024
- Phage therapy: From biological mechanisms to future directionsCell, 2023
- Bacteriophage Isolation, Purification, and Characterization Techniques Against Ubiquitous Opportunistic PathogensCurrent Protocols, 2022
- Gene sequencing analysis of tailed phages identified diverse (Kayfunavirus and Berlinvirus) coliphages in aquatic niche against AMR Escherichia coliArchives of Microbiology, 2022
- Isolation and characterization of bacteriophage NTR1 infectious for Nocardia transvalensis and other Nocardia speciesVirus Genes, 2018
- Basic Local Alignment Search ToolJournal of Molecular Biology, 1990